Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

Overview of attention for article published in Nature Medicine, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 50 news outlets
blogs: 7 blogs
twitter: 117 X users

facebook: 3 Facebook pages
wikipedia: 1 Wikipedia page
reddit: 3 Redditors

Readers on

mendeley: 109 Mendeley

So far, Altmetric has seen 4 public wall posts from 3 users.

Nature Medicine, 21 Jun 2023

The signaling-specific inhibitor AEF0117 selectively inhibits CB1 activation by THC and reduces self-administration and…

Psiconeurobiologia - Master II Livello, 14 Jun 2023

https://www.nature.com/articles/s41591-023-02381-w

Nature Medicine, 09 Jun 2023

The signaling-specific inhibitor AEF0117 selectively inhibits CB1 activation by THC and reduces self-administration and…

Nature Portfolio, 08 Jun 2023

A Nature Medicine paper reports on a potential new drug that could facilitate the treatment of cannabis addiction. The findings…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.